CoChat

Symptoms, the Nature of Fibromyalgia, and Diagnostic and Statistical Manual 5 (DSM-5) Defined Mental Illness in Patients with Rheumatoid Arthritis and Fibromyalgia

Open access

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Abstract

PURPOSE: To describe and evaluate somatic symptoms in patients with rheumatoid arthritis (RA) and fibromyalgia, determine the relation between somatization syndromes and fibromyalgia, and evaluate symptom data in light of the Diagnostic and Statistical Manual-5 (DSM-5) criteria for somatic symptom disorder. METHODS: We administered the Patient Health Questionnaire-15 (PHQ-15), a measure of somatic symptom severity to 6,233 persons with fibromyalgia, RA, and osteoarthritis. PHQ-15 scores of 5, 10, and 15 represent low, medium, and high somatic symptom severity cut-points. A likely somatization syndrome was diagnosed when PHQ-15 score was ≥10. The intensity of fibromyalgia diagnostic symptoms was measured by the polysymptomatic distress (PSD) scale. RESULTS: 26.4% of RA patients and 88.9% with fibromyalgia had PHQ-15 scores ≥10 compared with 9.3% in the general population. With each step-wise increase in PHQ-15 category, more abnormal mental and physical health status scores were observed. RA patients satisfying fibromyalgia criteria increased from 1.2% in the PHQ-15 low category to 88.9% in the high category. The sensitivity and specificity of PHQ-15≥10 for fibromyalgia diagnosis was 80.9% and 80.0% (correctly classified = 80.3%) compared with 84.3% and 93.7% (correctly classified = 91.7%) for the PSD scale. 51.4% of fibromyalgia patients and 14.8% with RA had fatigue, sleep or cognitive problems that were severe, continuous, and life-disturbing; and almost all fibromyalgia patients had severe impairments of function and quality of life. CONCLUSIONS: All patients with fibromyalgia will satisfy the DSM-5 "A" criterion for distressing somatic symptoms, and most would seem to satisfy DSM-5 "B" criterion because symptom impact is life-disturbing or associated with substantial impairment of function and quality of life. But the "B" designation requires special knowledge that symptoms are "disproportionate" or "excessive," something that is uncertain and controversial. The reliability and validity of DSM-5 criteria in this population is likely to be low.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0088740

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The relation of the PHQ-15 and Polysymptomatic Distress (PSD) scales. The vertical lines at 5, 10 and 15 define the PHQ-15 severity groups (0–4, 5–9, 10–14, ≥15). The horizontal line at 12 roughly separates fibromyalgia negative patients (<12) from mostly fibromyalgia criteria positive patients (≥12). A small amount if random jitter is added to the symbols to make overlapping symbols easier to see.
Figure 1 The relation of the PHQ-15 and Polysymptomatic Distress (PSD) scales. The vertical lines at 5, 10 and 15 define the PHQ-15 severity groups (0–4, 5–9, 10–14, ≥15). The horizontal line at 12 roughly separates fibromyalgia negative patients (<12) from mostly fibromyalgia criteria positive patients (≥12). A small amount if random jitter is added to the symbols to make overlapping symbols easier to see.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 83

Metadata

Authors
Wolfe, F., Walitt, B. T., Katz, R. S., & Häuser, W.
Affiliations
  • University of Kansas (US)
  • MedStar Washington Hospital Center (US)
  • Rush University Medical Center (US)
  • Klinikum Saarbrücken (DE)
Corresponding author
Wolfe, Frederick
Venue
PLoS ONE
Published
2014-02-14
Volume
9
Issue
2
Pages
e88740
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2008943218
Cited by
83
References
54
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 10 · 2021: 11 · 2020: 6 · 2019: 8 · 2018: 7 · 2017: 5 · 2016: 9 · 2015: 8 · 2014: 2
FWCI
6.11
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer
  • Daiichi-Sankyo
  • Cilag
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
fibromyalgia, rheumatoid arthritis, somatic symptoms, somatic symptom disorder, DSM-5 diagnostic criteria, PHQ-15, fatigue, sleep disorders, cognitive complaints, quality of life, sensitivity and specificity, osteoarthritis, mental illness, comorbidities, functional disability
MeSH terms
Aged, Arthritis, Rheumatoid, Mental Disorders, Cognition, Fatigue, Female, Fibromyalgia, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Surveys and Questionnaires, Sleep, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Symptoms, the Nature of Fibromyalgia, and Diagnostic and Statistical Manual 5 (DSM-5) Defined Mental Illness in Patients with Rheumatoid Arthritis and Fibromyalgia. https://app.cochat.ai/papers/10.1371/journal.pone.0088740
The paper
Wolfe, F., Walitt, B. T., Katz, R. S., & Häuser, W. (2014). Symptoms, the Nature of Fibromyalgia, and Diagnostic and Statistical Manual 5 (DSM-5) Defined Mental Illness in Patients with Rheumatoid Arthritis and Fibromyalgia. PLoS ONE. https://doi.org/10.1371/journal.pone.0088740

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.